Recent Finacing
Recent Raise
Delphia Therapeutics develops targeted cancer medicines using an activation-lethality platform that integrates tumor genetics, functional genomics, and drug-resistance studies to hyperactivate oncogene pathways and selectively kill tumor cells.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
